Tilman Brummer

Stefan Meier Str. 17
Freiburg, BW 79104, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 111 publications

Exploring the pathway: clinical utility and open challenges of targeting BRAF alterations in biliary tract cancers and gastrointestinal malignancies.

Exploring the pathway: clinical utility and open challenges of targeting BRAF alterations in biliary tract cancers and gastrointestinal malignancies.

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

Molecular Tumor Boards in Malignant Melanoma: Uncovering Challenges and Opportunities in a Bicenter Retrospective Analysis in Germany.

Molecular Tumor Boards in Malignant Melanoma: Uncovering Challenges and Opportunities in a Bicenter Retrospective Analysis in Germany.

Journal: International journal of cancer

Published: December 18, 2025

Novel Syngeneic Cell Lines for Studying High-Risk BRAFV600E-Driven Colorectal Cancer In Vivo.

Novel Syngeneic Cell Lines for Studying High-Risk BRAFV600E-Driven Colorectal Cancer In Vivo.

Journal: Cancer research communications

Published: October 01, 2025

Impact of non-genetic heterogeneity of BRAF-mutant colon cancer organoids on growth kinetics, drug sensitivity and Wnt dynamics.

Impact of non-genetic heterogeneity of BRAF-mutant colon cancer organoids on growth kinetics, drug sensitivity and Wnt dynamics.

Journal: International journal of cancer

Published: September 29, 2025

FLT3-ITD Induces CMTM6 and Enhances Immune Escape in Acute Myeloid Leukemia.

FLT3-ITD Induces CMTM6 and Enhances Immune Escape in Acute Myeloid Leukemia.

Journal: Cancer research

Published: January 27, 2025

Treatment outcome of NSCLC patients with BRAFnon-V600E mutations: a retrospective, multicentre analysis within the national Network Genomic Medicine (nNGM) Lung Cancer in Germany.

Treatment outcome of NSCLC patients with BRAFnon-V600E mutations: a retrospective, multicentre analysis within the national Network Genomic Medicine (nNGM) Lung Cancer in Germany.

Journal: ESMO open

Published: January 08, 2025

Multi-omics dissection of MAPK-driven senescence unveils therapeutic vulnerabilities in KIAA1549::BRAF-fusion pediatric low-grade glioma models.

Multi-omics dissection of MAPK-driven senescence unveils therapeutic vulnerabilities in KIAA1549::BRAF-fusion pediatric low-grade glioma models.

Journal: Signal transduction and targeted therapy

Published: November 06, 2024

Saturation mutagenesis identifies activating and resistance-inducing FGFR kinase domain mutations.

Saturation mutagenesis identifies activating and resistance-inducing FGFR kinase domain mutations.

Journal: Nature genetics

Published: July 17, 2024

The mTOR pathway controls phosphorylation of BRAF at T401.

The mTOR pathway controls phosphorylation of BRAF at T401.

Journal: Cell communication and signaling : CCS

Published: June 08, 2024

Enzyme Is the Name-Adapter Is the Game.

Enzyme Is the Name-Adapter Is the Game.

Journal: Cells

Published: April 30, 2024

Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors.

Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors.

Journal: NPJ precision oncology

Published: April 29, 2024

MOST wanted: navigating the MAPK-OIS-SASP-tumor microenvironment axis in primary pediatric low-grade glioma and preclinical models.

MOST wanted: navigating the MAPK-OIS-SASP-tumor microenvironment axis in primary pediatric low-grade glioma and preclinical models.

Journal: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery

Published: March 28, 2024

Showing 1-12 of 111

Last Updated: 09/26/2026